Equities Research Analysts’ Upgrades for January 12th (ABCL, AKAM, AWK, CMCSA, CRNX, DSGX, FRO, FWONK, KRMD, LAR)

Equities Research Analysts’ upgrades for Monday, January 12th:

AbCellera Biologics (NASDAQ:ABCL) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Akamai Technologies (NASDAQ:AKAM) was upgraded by analysts at Morgan Stanley from an underweight rating to an overweight rating. They currently have $115.00 price target on the stock, up from their previous price target of $83.00.

American Water Works (NYSE:AWK) was upgraded by analysts at Bank of America Corporation from an underperform rating to a neutral rating. The firm currently has $139.00 price target on the stock, up from their previous price target of $117.00.

Comcast (NASDAQ:CMCSA) was upgraded by analysts at Bank of America Corporation from a neutral rating to a buy rating. Bank of America Corporation currently has $37.00 target price on the stock, up from their previous target price of $31.00.

Crinetics Pharmaceuticals (NASDAQ:CRNX) was upgraded by analysts at The Goldman Sachs Group, Inc. from a neutral rating to a buy rating. They currently have $67.00 price target on the stock.

The Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating. Barclays PLC currently has $105.00 target price on the stock, down from their previous target price of $106.00.

Frontline (NYSE:FRO) was upgraded by analysts at Clarkson Capital from a neutral rating to a buy rating.

Liberty Media Corporation – Liberty Formula One Series C (NASDAQ:FWONK) was upgraded by analysts at Sanford C. Bernstein from a market perform rating to an outperform rating. Sanford C. Bernstein currently has $111.00 target price on the stock, up from their previous target price of $110.00.

KORU Medical Systems (NASDAQ:KRMD) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Lithium Americas (Argentina) (NYSE:LAR) was upgraded by analysts at Scotiabank from a sector perform rating to a sector outperform rating. The firm currently has $7.75 price target on the stock, up from their previous price target of $4.25.

OceanFirst Financial (NASDAQ:OCFC) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Oportun Financial (NASDAQ:OPRT) was upgraded by analysts at Wall Street Zen from a buy rating to a strong-buy rating.

Oportun Financial (NASDAQ:OPRT) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating. The firm currently has $5.50 target price on the stock.

Palantir Technologies (NASDAQ:PLTR) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating. They currently have $235.00 price target on the stock, up from their previous price target of $210.00.

RLX Technology (NYSE:RLX) was upgraded by analysts at Wall Street Zen from a sell rating to a hold rating.

Trex (NYSE:TREX) was upgraded by analysts at DA Davidson from a neutral rating to a buy rating. The firm currently has $50.00 price target on the stock, up from their previous price target of $45.00.

Zoom Communications (NASDAQ:ZM) was upgraded by analysts at Citigroup Inc. from a neutral rating to a buy rating. Citigroup Inc. currently has $106.00 target price on the stock, up from their previous target price of $94.00.

Receive News & Ratings for AbCellera Biologics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AbCellera Biologics Inc and related companies with MarketBeat.com's FREE daily email newsletter.